
pmid: 35656746
pmc: PMC9373193
handle: 20.500.11768/140412 , 2434/936490 , 11390/1230424 , 11567/1094257 , 11568/1145996 , 2318/1948965
pmid: 35656746
pmc: PMC9373193
handle: 20.500.11768/140412 , 2434/936490 , 11390/1230424 , 11567/1094257 , 11568/1145996 , 2318/1948965
The circadian rhythms originate within the organism and synchronize with cyclic fluctuations in the external environment. It has been demonstrated that part of the human genome is under control of the circadian clock and that a synchronizer that helps to maintain daily rhythms is Melatonin, a neuro-hormone primarily synthesized by the pineal gland during the night. The chronic disruption of circadian rhythm has been linked to many conditions such as obesity, metabolic syndrome, type 2 diabetes, cancer, and neurodegenerative diseases. Studies in the mice showed that the disruption of the retinal circadian rhythm increases the decline during the aging of photoreceptors, accelerating age-related disruption of cone cell structure, function, and viability and that the melatonin receptor deletion seems to influence the health of retinal cells, speeding up their aging. In conclusion, preserving the circadian rhythms could be to add to the prevention and treatment of age-related degenerative retinal diseases, and although additional studies are needed, melatonin could be a valid support to favor this “chronoprotection action”.
age related macular degeneration; chronoprotection; Circadian rhythm; melatonin, chronoprotection, Consensus, Animals; Circadian Rhythm/physiology; Consensus; Diabetes Mellitus, Type 2/metabolism; Humans; Melatonin/metabolism; Melatonin/pharmacology; Mice; Retina/physiology; Circadian rhythm; age related macular degeneration; chronoprotection; melatonin, Circadian rhythm, age related macular degeneration, age related macular degeneration; chronoprotection; Circadian rhythm; melatonin; Animals; Circadian Rhythm; Consensus; Humans; Mice; Retina; Diabetes Mellitus, Type 2; Melatonin, melatonin, Retina, Circadian Rhythm, Mice, Editorial, Diabetes Mellitus, Type 2, Animals, Humans, Melatonin
age related macular degeneration; chronoprotection; Circadian rhythm; melatonin, chronoprotection, Consensus, Animals; Circadian Rhythm/physiology; Consensus; Diabetes Mellitus, Type 2/metabolism; Humans; Melatonin/metabolism; Melatonin/pharmacology; Mice; Retina/physiology; Circadian rhythm; age related macular degeneration; chronoprotection; melatonin, Circadian rhythm, age related macular degeneration, age related macular degeneration; chronoprotection; Circadian rhythm; melatonin; Animals; Circadian Rhythm; Consensus; Humans; Mice; Retina; Diabetes Mellitus, Type 2; Melatonin, melatonin, Retina, Circadian Rhythm, Mice, Editorial, Diabetes Mellitus, Type 2, Animals, Humans, Melatonin
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 8 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
